The historical rank and industry rank for Titan Pharmaceuticals's FCF Margin % or its related term are showing as below:
TTNP'
s FCF Margin % Range Over the Past 10 Years
Min: -709400 Med: -528.75 Max: 40.64
Current: -709200
During the past 13 years, the highest FCF Margin % of Titan Pharmaceuticals was 40.64%. The lowest was -709400.00%. And the median was -528.75%.
TTNP's FCF Margin % is ranked worse than 99.71% of 1037
companies
in the Biotechnology industry
Industry Median: -147.18
vs TTNP: -709200.00
Titan Pharmaceuticals FCF Margin % Historical Data
The historical data trend for Titan Pharmaceuticals's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Titan Pharmaceuticals's FCF Margin %
For the Biotechnology subindustry, Titan Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Titan Pharmaceuticals's FCF Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Titan Pharmaceuticals's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Titan Pharmaceuticals's FCF Margin % falls into.
Titan Pharmaceuticals FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Titan Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Titan Pharmaceuticals FCF Margin % Related Terms
Thank you for viewing the detailed overview of Titan Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Titan Pharmaceuticals (Titan Pharmaceuticals) Business Description
Titan Pharmaceuticals Inc is a pharmaceutical company developing therapeutics utilizing its proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases for which steady state delivery of a drug provides efficacy and/or safety benefit. ProNeura consists of a small, solid implant made from a mixture of ethylene-vinyl acetate, or EVA, and a drug substance. Its first product based on ProNeura technology was the Probuphine (buprenorphine) implant, which was approved in the United States, Canada and the European Union, for the maintenance treatment of opioid use disorder in clinically stable patients taking 8 mg or less a day of oral buprenorphine.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TTNP has been successfully added to your 